Riskpilot← Back to searchSign inGet full accessDeniCare AB
ABActiveOrg 5593154692Uppåkragatan 6General medical practice activities · NACE 8621Est. 20210 employees
Revenue 2024
SEK 2M
-2% vs 2023
EBITDA margin
-0.9%
-105% vs 2023
Equity ratio
84.8%
Financial strength
Net profit 2024
SEK -45K
-117% vs 2023
| Revenue | SEK 2M | -2% |
| EBITDA | SEK -18K | -105% |
| Net profit | SEK -45K | -117% |
| Total assets | SEK 396K | -30% |
| Equity | SEK 335K | -24% |
| Employees | 0 | — |
Legal name
DeniCare AB
Org number
5593154692
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
3 maj 2021
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget har till föremål för sin verksamhet att bedriva konsulting inom digital hälsovård samt utföra skönhetsbehandlingar, där rekommendationer grundas på certifierad yrkesskicklighet med patientsäkerhet i fokus.
Address
Uppåkragatan 6
Email
info@denicare.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 364 | 1 327 | 2 026 | 1 991 |
| Staff expenses | — | — | −53 | −148 |
| EBITDA | 175 | 440 | 370 | −18 |
| Depreciation & amort. | −0 | −14 | −24 | −22 |
| EBIT | 175 | 426 | 345 | −41 |
| Net financials | — | −1 | −1 | −1 |
| Profit before tax | 175 | 425 | 344 | −42 |
| Tax | −37 | −91 | −76 | −3 |
| Net profit | 138 | 334 | 268 | −45 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 209 | 449 | 565 | 396 |
| Equity | 163 | 367 | 440 | 335 |
| Long-term debt | 0 | 0 | — | — |
| Short-term debt | 46 | 82 | 125 | 60 |
| Total debt | 46 | 82 | 125 | 60 |
EBITDA margin
-0.9%
This company
15.8%
Market median
-106% vs market
20212024
Equity ratio
84.8%
This company
38.2%
Market median
+122% vs market
20212024
Return on equity
-13.4%
This company
18.4%
Market median
-173% vs market
20212024
Net profit margin
-2.3%
This company
8.1%
Market median
-128% vs market
20212024
Asset turnover
5.03×
This company
1.12×
Market median
+349% vs market
20212024
Debt / equity
0.18×
This company
0.62×
Market median
+71% vs market
20212024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-05-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
DT Chief Executive Officer | Chief Executive Officer | 2022 |
AT Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2022 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of DeniCare AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Denisa Talic | Chief Executive Officer | 0 companies |
| Ajdin Talic | Deputy Chief Executive Officer | 0 companies |